Essential Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$228K Buy
366
+43
+13% +$25.2K 0.1% 210
2026
Q2
$171K Sell
323
-1,442
-82% -$665K 0.08% 277
2026
Q1
$848K Sell
1,765
-776
-31% -$397K 0.29% 83
2025
Q4
$1.43M Buy
2,541
+478
+23% +$271K 0.44% 52
2025
Q3
$1.06M Buy
2,063
+697
+51% +$304K 0.35% 73
2025
Q2
$429K Buy
+1,366
New +$410K 0.17% 175

Other funds holding MEDP

Essential Partners's MEDP Position: Q3 2026 in Review

Essential Partners increased its Medpace (MEDP) stake by 13% in Q3 2026, buying an estimated $25.2K and bringing the position to 366 shares worth $228K. The position accounts for 0.1% of the portfolio, ranked #210.

Essential Partners first reported a position in MEDP in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.43M in Q4 2025. 91 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Essential Partners held 366 shares of Medpace worth $228K as of Q3 2026.
  • Essential Partners bought 43 Medpace shares in Q3 2026, an estimated $25.2K.
  • Medpace made up 0.1% of Essential Partners's portfolio in Q3 2026, its #210 holding.
  • Essential Partners first reported a position in Medpace in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Medpace position peaked at $1.43M in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.